Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

The AHA March 5 expressed support for legislation (S. 3399) to extend for five additional years the Frontier Community Health Integration Project (FCHIP) demonstration. Launched in 2016, the FCHIP aims to better integrate and coordinate care, and reduce avoidable hospitalizations, admissions and transfers to distant providers.
The AHA today urged the Department of Health and Human Services to take a number of regulatory actions that would help hospitals and health systems better prepare for and respond to the novel coronavirus (COVID-19) outbreak. Among other actions, AHA urged HHS to enable broader use of telehealth and help preserve the supply of N95 respirators.
AHA, health organizations letter to Senate Chairman, Lamar Alexander and Ranking Member Patty Murray, expressing support of S.2723 - The Mitigating Emergency Drug Shortages (MEDS) Act.
 AHA, health organizations letter to Representatives Peters, Engel, Eshoo, Schrader, Guthrie, Hudson, McCaul, and Bilirakis, supporting the Preventing Drug Shortages Act. 
AHA comments on the Centers for Medicare & Medicaid Services's (CMS), Part II of the Medicare Advantage (MA) and Part D Advance Notice. In particular, the AHA appreciates the CMS’ ongoing efforts to solicit stakeholder feedback on how to improve the MA Star Ratings Program, and we encourage the agency to develop and incorporate into that program measures related to prior authorization.
AHA comments to CMS on Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021.
The AHA and American Nurses Association urge Congress to “swiftly provide” $1 billion in initial supplemental emergency funding to support the “urgent preparedness and response needs of hospitals, health systems, physicians and nurses on the front lines” of the novel coronavirus outbreak.
AHA letter to Senators Rick Scott, R-Fla., Marco Rubio, R-Fla., and Tom Cotton, R-Ark., in respond to their questions on efforts to protect U.S. taxpayer-funded research developed at our member organizations from foreign threats.
AHA, others urge Senate HELP Committee to advance MEDS Act (S.2723).
AHA comments to the U.S. House of Representatives Committee on Education and Labor on provisions of the Ban Surprise Billing Act that will be marked up this week.